Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

PCOS may increase the risk of mental health issues like depression and anxiety.

Neurosteroids help regulate oxytocin levels, especially during stress and pregnancy, to protect against premature labor.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

17β-estradiol can reduce inflammation in the skin.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Sex hormones, especially androgens, play a key role in causing acne.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Valproate is a mood stabilizer for bipolar disorder but has side effects and risks, especially during pregnancy.

Female pattern hair loss, common in women, can be treated with various methods like minoxidil, anti-androgen treatments, and light therapy, but early intervention and realistic expectations are crucial.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Both estrogens and androgens are important for health in both males and females.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Spironolactone is effective and safe for treating hair loss, excessive hair growth, and acne.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.